UF Innovate | The Hub News

UF Innovate | The Hub News

Oxidien Pharmaceuticals Announce Addition to Scientific and Medical Advisory Board

UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease indication, announced three additions to its Scientific and Medical Advisory Board (SMAB) to provide external advice on its development activities and clinical program in secondary hyperoxaluria. Helena Cowley,...
Read More

Selecting a Microbiome CDMO Partner for the Long Term, Arranta Bio Shares

As more microbiome-based therapies progress through the clinic toward approval for market launch, concerns over the lack of outsourcing capacity for process development and commercial manufacturing of live biotherapeutic products are increasing. Arranta Bio is investing heavily in both its process development and cGMP manufacturing capabilities for the supply of...
Read More

UF Ranked No. 1 Nationally in Innovation Impact

The University of Florida is the most productive large university in the country at leveraging its research funding into new companies, new jobs and new ideas, according to a report released last week by the George W. Bush Institute and the Opus Faveo Innovation Development consulting firm. A team of...
Read More

UF Innovate | The Hub Celebrates 10 Years Since Groundbreaking

UF Innovate | The Hub is a place where entrepreneurs take a creative idea and make it into a legitimate business. In the past 10 years, 108 businesses began their journey there. “There wasn’t any real formal support for entrepreneurs and first-time startup founders in the Gainesville area. This was...
Read More

Oxidien Among Top Three Winners of Digital RESI June Innovation Challenge

The 3-day Digital RESI June conference announced the Top 3 Winners of the Innovation Challenge. UF Innovate | The Hub resident client Oxidien Pharmaceuticals was among the winners. Watch Oxidien’s virtual poster, short pitch, and other supplementary materials here. Oxidien Pharmaceuticals is a clinical-stage drug development company developing a treatment for enteric hyperoxaluria,...
Read More

ReWalk Expands Product Offerings in Deal With Myolyn, LLC

Marlborough medical device manufacturer ReWalk Robotics has entered into two agreements to distribute product lines to the U.S. market from two companies in Florida and Israel. One of the companies is UF startup and UF Innovate | The Hub graduate company Myolyn. The Myolyn MyoCycle Functional Electrical Stimulation products facilitate...
Read More